CNAD.F Stock Overview
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CanadaBis Capital Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.04 |
| 52 Week High | CA$0.22 |
| 52 Week Low | CA$0.025 |
| Beta | 0.21 |
| 11 Month Change | -6.32% |
| 3 Month Change | -8.30% |
| 1 Year Change | -78.14% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNAD.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.6% |
| 1Y | -78.1% | 17.2% | 30.8% |
Return vs Industry: CNAD.F underperformed the US Pharmaceuticals industry which returned 17.2% over the past year.
Return vs Market: CNAD.F underperformed the US Market which returned 30.8% over the past year.
Price Volatility
| CNAD.F volatility | |
|---|---|
| CNAD.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CNAD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CNAD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Travis McIntyre | www.canadabis.com |
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extract. The Cultivation and Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards.
CanadaBis Capital Inc. Fundamentals Summary
| CNAD.F fundamental statistics | |
|---|---|
| Market cap | US$5.97m |
| Earnings (TTM) | US$1.57m |
| Revenue (TTM) | US$13.55m |
3.5x
P/E Ratio0.4x
P/S RatioIs CNAD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNAD.F income statement (TTM) | |
|---|---|
| Revenue | CA$18.83m |
| Cost of Revenue | CA$8.49m |
| Gross Profit | CA$10.34m |
| Other Expenses | CA$8.16m |
| Earnings | CA$2.18m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.016 |
| Gross Margin | 54.90% |
| Net Profit Margin | 11.56% |
| Debt/Equity Ratio | 73.9% |
How did CNAD.F perform over the long term?
See historical performance and comparison